Literature DB >> 8699069

Molecular analysis of strains of Plasmodium vivax from paired primary and relapse infections.

A A Craig1, K C Kain.   

Abstract

Relapse infections are an important obstacle to the successful treatment and control of Plasmodium vivax malaria, but the molecular basis of relapse remains poorly understood. To provide insight into the molecular mechanisms of relapse, paired primary and relapse isolates of P. vivax were subjected to single-strand conformational polymorphism (SSCP) and sequence analysis of the circumsporozoite and merozoite surface protein 1 genes. All unrelated isolates were unique by both SSCP and sequence analysis, but 5 of 6 relapse isolates were identical to or were clones of their matched primary isolates. These results indicate that most relapses are caused by the same parasite populations that circulate during the primary infection and do not arise from a genetically distinct subpopulation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8699069     DOI: 10.1093/infdis/174.2.373

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  22 in total

Review 1.  Chloroquine resistance in Plasmodium vivax.

Authors:  J Kevin Baird
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

Review 2.  Uncovering the transmission dynamics of Plasmodium vivax using population genetics.

Authors:  Alyssa E Barry; Andreea Waltmann; Cristian Koepfli; Celine Barnadas; Ivo Mueller
Journal:  Pathog Glob Health       Date:  2015-04-18       Impact factor: 2.894

3.  Genetic Variation of MSP-1 Gene in Plasmodium vivax Isolated from Patients in Hormozgan Province, Iran using SSCP-PCR.

Authors:  A Miahipour; H Keshavarz; A Heidari; A Raeisi; M Rezaeian; S Rezaie
Journal:  Iran J Parasitol       Date:  2012       Impact factor: 1.012

4.  Evolutionary dynamics of the immunodominant repeats of the Plasmodium vivax malaria-vaccine candidate circumsporozoite protein (CSP).

Authors:  Aarti Patil; Pamela Orjuela-Sánchez; Mônica da Silva-Nunes; Marcelo U Ferreira
Journal:  Infect Genet Evol       Date:  2010-01-25       Impact factor: 3.342

5.  Modeling Plasmodium vivax: relapses, treatment, seasonality, and G6PD deficiency.

Authors:  Farida Chamchod; John C Beier
Journal:  J Theor Biol       Date:  2012-08-29       Impact factor: 2.691

6.  Microgeographical differences of Plasmodium vivax relapse and re-infection in the Peruvian Amazon.

Authors:  Raul Chuquiyauri; Pablo Peñataro; Kimberly C Brouwer; Manuel Fasabi; Maritza Calderon; Sonia Torres; Robert H Gilman; Margaret Kosek; Joseph M Vinetz
Journal:  Am J Trop Med Hyg       Date:  2013-07-08       Impact factor: 2.345

7.  Establishment of an in vitro assay for assessing the effects of drugs on the liver stages of Plasmodium vivax malaria.

Authors:  Rana Chattopadhyay; Soundarapandian Velmurugan; Chinnamma Chakiath; Lucy Andrews Donkor; Wilbur Milhous; John W Barnwell; William E Collins; Stephen L Hoffman
Journal:  PLoS One       Date:  2010-12-09       Impact factor: 3.240

8.  Determination of the Plasmodium vivax relapse pattern in Camopi, French Guiana.

Authors:  Matthieu Hanf; Aurélia Stéphani; Célia Basurko; Mathieu Nacher; Bernard Carme
Journal:  Malar J       Date:  2009-12-04       Impact factor: 2.979

9.  Molecular and epidemiological characterization of Plasmodium vivax recurrent infections in southern Mexico.

Authors:  Lilia Gonzalez-Ceron; Jianbing Mu; Frida Santillán; Deirdre Joy; Marco A Sandoval; Gerardo Camas; Xinzhuan Su; Elena V Choy; Rene Torreblanca
Journal:  Parasit Vectors       Date:  2013-04-18       Impact factor: 3.876

10.  Multiple-clone activation of hypnozoites is the leading cause of relapse in Plasmodium vivax infection.

Authors:  Flávia Carolina F de Araujo; Antônio Mauro de Rezende; Cor Jesus F Fontes; Luzia Helena Carvalho; Cristiana F Alves de Brito
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.